CD8A and neoplasm: Furthermore, mutations in IDH promote derivation of the oncogenic metabolite, 2-HG, which limits the production of chemokines, CXCL9 and CXCL10, by downregulating STAT1, resulting in reduced infiltration of CD8+ T cells and tumor escape [119].